ITI Focused Fund
The scheme seek to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 companies across market capitalization.
Growthvine rating: 3/5 — ranked #9 of 28 in category.
Fund basics
| Category | Equity: Focused |
|---|
| NAV | ₹16.18 (as of 2026-11-13) |
|---|
| AUM | ₹607 Cr |
|---|
| Expense ratio | 2.07% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Alok Ranjan |
|---|
| Exit load | 0.5% for redemption within 3 months |
|---|
Performance & risk
| Sharpe ratio | 0.52 |
|---|
| Standard deviation | 16.85% |
|---|
| Max drawdown | −19.04% |
|---|
| Alpha | 3.42 |
|---|
| Beta | 1.04 |
|---|
Over 5 years, captured 109.6% of Nifty 500's upside and 94.5% of its downside.
Market cap allocation
| Large cap | 58.8% |
|---|
| Mid cap | 13.7% |
|---|
| Small cap | 27.5% |
|---|
Concentration
| Top 5 holdings | 22.4% |
|---|
| Top 10 holdings | 41.2% |
|---|
| Total holdings | 29 |
|---|
| Index overlap | 30.3% |
|---|
| Active share | 69.7% |
|---|
Top holdings
- ICICI Bank Ltd. — 5.4%
- Net Receivables / (Payables) — 4.9%
- Wockhardt Ltd — 4.4%
- Multi Commodity Exchange of India Ltd — 4.3%
- Reliance Industries Ltd — 4.2%
- Graphite India Ltd. — 4.1%
- HDFC Bank Ltd. — 4.1%
- Solar Industries India Limited — 3.9%
- State Bank Of India — 3.7%
- Sun Pharmaceutical Industries Ltd. — 3.6%
Top sectors
- Banking & Financial — 20.1%
- Industrial Products — 16.2%
- Pharma & Biotech — 8.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 1.8% | Q3 | #19 of 28 |
| 2025 | 7.7% | Q1 (Top) | #7 of 28 |
| 2024 | 24.5% | Q1 (Top) | #4 of 27 |